CClinicalTrials.gg
CompletedNCT03712995Updated Dec 10, 2018

Reconstruction of Upper Eyelid With a Newly Modified Cutler-Beard Technique With Tarsoconjunctival Graf

An interventional study of 'Cutler-Beard modified with graft' in Reconstructive Surgical Procedure, sponsored by Hospital Universitario 12 de Octubre. Completed. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2018-12-10.

Sponsored by Hospital Universitario 12 de Octubre · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 years 9 months after the study started (first participant enrolled Jan 2011, registered Oct 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years to 90 Years
Sex
All
01

Study summary

To study the results of a modified Cutler-Beard technique , using a contralateral tarsoconjunctival graft, in patients who underwent excision of large malignant tumors of the upper eyelid

Read the detailed description

A tarsoconjunctival graft was harvested from the contralateral upper eyelid, with an extra 3 mm of conjunctiva from the superior edge of tarsus and was attached to the upper eyelid defect, differently than previously described.

Functional, cosmetic outcomes and postoperative complications were evaluated.

02

Conditions studied

  • Reconstructive Surgical Procedure

Keywords

  • Cutler-Beard
  • tarsoconjunctival graft
  • upper eyelid
03

In context

Lead sponsor

Hospital Universitario 12 de Octubre is the lead sponsor of 33 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Upper eyelid defect after tumor resection

Exclusion criteria

Exclusion Criteria:

  • previous surgery
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    Cutler-Beard modified with graft

    Reconstruction of Upper Eyelid With a Newly Modified Cutler-Beard Technique With Tarsoconjunctival Graf

    Procedure: 'Cutler-Beard modified with graft'

Interventions

  • Procedure'Cutler-Beard modified with graft'

    A tarsoconjunctival graft was harvested from the contralateral upper eyelid, with an extra 3 mm of conjunctiva from the superior edge of tarsus and was attached to the upper eyelid defect, differently than previously described.

    Also known as: Modified Cutler-Beard technique with tarsoconjunctival graft

06

What researchers measure

Primary outcomes

  1. Eyelid retraction

    Upper eyelid retraction in mm

    Time frame: 42 months

Secondary outcomes

  1. Retraction of the donor lower eyelid

    Lower eyelid retraction in mm

    Time frame: 42 months

  2. Lagophthalmos

    Excessive aperture of the eyelids, in mm

    Time frame: 42 months

  3. Lid margin stability

    in mm

    Time frame: 42 months

  4. Eyelid status

    Number of complications, being 0 the best result

    Time frame: 42 months

Other outcomes

  1. Symptoms of the patients

    Number of symptoms referred by the patient, being 0 the best result

    Time frame: 42 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Publication of the results in a journal

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 10, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03712995
Lead sponsor
Hospital Universitario 12 de Octubre
Responsible party
Sponsor
First posted
Oct 19, 2018
Start date
Jan 1, 2011
Primary completion
Dec 31, 2016
Completion
Dec 31, 2016
Last update
Dec 10, 2018

Study contacts

Enrique Mencía-Gutiérrez, MD
study chair · Hospital Universitario 12 de Octubre, Madrid, Spain

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion